MASCC/ISOO 2012 International Symposium focuses on the clinical management of supportive care in oncology.

The 

MASCC/ISOO 2012 International Symposium focuses on the clinical management of supportive care in oncology. It is essential that all oncology specialists, care-givers and cancer policy makers are fully updated as to the latest available physical and psychological treatments to prevent, control, or relieve complications and side effects of cancer and its treatments — including antineoplastic approaches. This advanced scientific oncology congress is endorsed by the leading Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology.Let’s meet in the exhilarating city of New York to combine our efforts and knowledge to explore how we can all improve patient's comfort and quality of life!

Mucositis Research Workshop

The Mucositis Research Workshop is centered around presentation of original research by young and experienced investigators. It provides an informal venue for detailed discussion beyond what is possible during the formal symposium. Such a workshop has been held in conjunction with the annual MASCC/ISOO symposium for 4 years previously. Workshop 

attendees represent thought leaders and investigators in the field of mucositis from all over the world. Invited experts and young investigators present and discuss the latest advances in mucositis research and identify new opportunities for research and collaborations.

III Jornada Paulista de Cirurgia de CCP

III Jornada Paulista de Cirurgia de Câncer de Cabeça e Pescoço
7 a 8 de dezembro de 2012

Taiwan reports highest oral cancer survivor rate

Taiwan reports highest oral cancer survivor rate
Wed, Mar 7, 2012Oral Cancer News

Source: www.chinapost.com.tw/
Taiwan has reported the highest five-year survival rate for patients with oral cancer in the world, a hospital official said yesterday.
On average, more than 70 percent of the oral cancer patients treated at National Taiwan University Hospital (NTUH) live for more than five years after being diagnosed, said Ko Jeng-yuh, head of the hospital’s division of head and neck oncology.
Citing a survey carried out by the American Joint Committee on Cancer, Ko said the survival rate in the United States for such patients in late stages of the disease was lower than 30 percent in 2010.
The NTUH treated 1,288 patients with oral cancer between 2004 and 2009 and after complete treatment, more than 55 percent of the 476 stage-four patients lived for at least five more years, the hospital said.
Taiwan has the world’s highest number of patients suffering from oral cancer, as the majority of patients are middle-aged men who are also the bread winners for their families, said Lou Pei-jen, an NTUH doctor.

Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials

BMJ. 2003 December 20; 327(7429): 1459–1461. doi:  10.1136/bmj.327.7429.1459

Gordon C S Smith, professor¹ and Jill P Pell, 

O fato de não haver Ensaios Clínicos Controlados e Randomizados na literatura, não quer dizer que não há evidências sólidas sobre o assunto. Uma análise crítica sobre nossos dias muito interessante com algum grau de ironia.